Creating a research data network for cardiovascular disease: The CVRN

Expert Review of Cardiovascular Therapy

Volumn 6, Issue 8, 2008, Pages 1043-1045

  Magid, David J ^a,e   Gurwitz, Jerry H ^b   Rumsfeld, John S ^c,e,f   Go, Alan S ^d  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d DIVISION OF RESEARCH   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f Kaiser Permanente Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; CARVEDILOL; CLOPIDOGREL; METOPROLOL TARTRATE; THIAZIDE DIURETIC AGENT; WARFARIN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DEFIBRILLATOR; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; EARLY DIAGNOSIS; EDITORIAL; FUNDING; HEALTH CARE; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH SURVEY; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; INFORMATION SYSTEM; MEDICAL RESEARCH; OUTCOME ASSESSMENT; RISK FACTOR; STROKE; VENOUS THROMBOEMBOLISM;

BIOMEDICAL RESEARCH; CARDIOVASCULAR DISEASES; DATA COLLECTION; HUMANS; INFORMATION SERVICES; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (U.S.); PROGRAM DEVELOPMENT; UNITED STATES;

EID: 55349132053     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.6.8.1043     Document Type: Editorial

References (6)

1. US Department of Health and Human Services. Healthy People 2010: Understanding and Improving Health and Objectives for Improving Health (Volume 1). US Government Printing Office, Washington, DC, USA (2000).
2. Goff DC Jr, Brass L, Braun LT et al. Essential features of a surveillance system to support the prevention and management of heart disease and stroke. A scientific statement from the American Heart Association Councils on epidemiology and prevention, stroke, and cardiovascular nursing and the interdisciplinary working groups on quality of care and outcomes research and atherosclerotic peripheral vascular disease. Circulation 115(1), 127-155 (2006).
3. Drazen JM, Morrissey S, Curfman GD. Rosiglitazone - continued uncertainty about safety. N. Engl. J. Med. 357(1), 63-64 (2007).
4. Curfman GD, Morrissey S, Jarcho JA, Drazen JM. Drug-eluting coronary stents - promise and uncertainty. N. Engl. J. Med. 356(10), 1059-1060 (2007).
5. Vogt TM, Elston-Lafata J, Tolsma D, Greene SM. The role of research in integrated healthcare systems: the HMO Research Network. Am. J. Manag. Care 10, 643-648 (2004).
6. Go AS, Yang J, Gurwitz JH, Hsu J, Lane K, Platt R. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure. Am. J. Cardiol. 100(4), 690-696 (2007).